CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hines, S. J.
Right arrow Articles by Krystal, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hines, S. J.
Right arrow Articles by Krystal, G. W.

Cell Growth & Differentiation, Vol 6, Issue 6 769-779, Copyright © 1995 by American Association of Cancer Research


ARTICLES

Coexpression of the c-kit and stem cell factor genes in breast carcinomas

SJ Hines, C Organ, MJ Kornstein and GW Krystal
Department of Medicine, Medical College of Virginia, Richmond 23249, USA.

Expression of the c-kit tyrosine kinase growth factor receptor has been reported in some breast tumors; however, no data exist concerning expression of its ligand, stem cell factor. The aim of this study was to determine how frequently the c-kit and stem cell factor genes were coexpressed in breast tumors and tumor-derived cell lines and to determine whether coexpression of c-kit and stem cell factor could result in growth stimulation of breast tumor cells. Expression of the c-kit and stem cell factor genes in tissue specimens and cell lines was determined using an RNase protection assay, with confirmation of c-kit protein expression by immunohistochemistry and Western blotting in tumor tissue and cell lines, respectively. Of 11 tumor specimens studied, 9 expressed variable but detectable quantities of c-kit; 7 of 13 tumor-derived cell lines also expressed c-kit. All tumor specimens and cell lines expressed detectable stem cell factor mRNA, suggesting that an autocrine growth loop could exist in the majority of breast carcinomas. To determine the biological effects of coexpression of c-kit and stem cell factor, the MCF-7 cell line, which expresses only stem cell factor, was transfected with a c-kit expression vector. Coexpression of c-kit and stem cell factor in MCF-7 cells resulted in an enhanced growth rate and cloning efficiency but not a loss of the dependence of this cell line upon estrogen. Analysis of subclones expressing different amounts of c-kit protein revealed that, although they all showed enhanced growth relative to control transfectants in serum-free medium containing IGF-1, only the highest c-kit expressor responded with additional growth to exogenous soluble stem cell factor. However, all c-kit-expressing clones, but not control clones, showed growth inhibition when exposed to a blocking anti-c-kit antibody. This blocking antibody also significantly inhibited the growth of the established ZR75-1 cell line in serum-free medium containing IGF-1. Taken together, these data suggest that coexpression of stem cell factor and c-kit could be responsible for growth deregulation in a significant number of breast carcinomas.


This article has been cited by other articles:


Home page
Anticancer ResHome page
A. IENI, G. GIUFFRE, V. ADAMO, and G. TUCCARI
Prognostic Impact of CD133 Immunoexpression in Node-negative Invasive Breast Carcinomas
Anticancer Res, April 1, 2011; 31(4): 1315 - 1320.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
H. Bougherara, F. Subra, R. Crepin, P. Tauc, C. Auclair, and M.-A. Poul
The Aberrant Localization of Oncogenic Kit Tyrosine Kinase Receptor Mutants Is Reversed on Specific Inhibitory Treatment
Mol. Cancer Res., September 1, 2009; 7(9): 1525 - 1533.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. J. Schilder, M. W. Sill, R. B. Lee, T. J. Shaw, M. K. Senterman, A. J. Klein-Szanto, Z. Miner, and B. C. Vanderhyden
Phase II Evaluation of Imatinib Mesylate in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study
J. Clin. Oncol., July 10, 2008; 26(20): 3418 - 3425.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. Catalano, S. Rodilossi, M. R. Rippo, P. Caprari, and A. Procopio
Induction of Stem Cell Factor/c-Kit/Slug Signal Transduction in Multidrug-resistant Malignant Mesothelioma Cells
J. Biol. Chem., November 5, 2004; 279(45): 46706 - 46714.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Boldrini, S. Ursino, S. Gisfredi, P. Faviana, V. Donati, T. Camacci, M. Lucchi, A. Mussi, F. Basolo, R. Pingitore, et al.
Expression and Mutational Status of c-kit in Small-Cell Lung Cancer: Prognostic Relevance
Clin. Cancer Res., June 15, 2004; 10(12): 4101 - 4108.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Kindler, F. Breitenbuecher, A. Marx, J. Beck, G. Hess, B. Weinkauf, J. Duyster, C. Peschel, C. J. Kirkpatrick, M. Theobald, et al.
Efficacy and safety of imatinib in adult patients with c-kit-positive acute myeloid leukemia
Blood, May 15, 2004; 103(10): 3644 - 3654.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T. J. Abrams, L. J. Murray, E. Pesenti, V. Walker Holway, T. Colombo, L. B. Lee, J. M. Cherrington, and N. K. Pryer
Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer
Mol. Cancer Ther., October 1, 2003; 2(10): 1011 - 1021.
[Abstract] [Full Text]


Home page
J. Virol.Home page
A. V. Moses, M. A. Jarvis, C. Raggo, Y. C. Bell, R. Ruhl, B. G. M. Luukkonen, D. J. Griffith, C. L. Wait, B. J. Druker, M. C. Heinrich, et al.
Kaposi's Sarcoma-Associated Herpesvirus-Induced Upregulation of the c-kit Proto-Oncogene, as Identified by Gene Expression Profiling, Is Essential for the Transformation of Endothelial Cells
J. Virol., August 15, 2002; 76(16): 8383 - 8399.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Perez-Losada, M. Sanchez-Martin, A. Rodriguez-Garcia, M. L. Sanchez, A. Orfao, T. Flores, and I. Sanchez-Garcia
Zinc-finger transcription factor Slug contributes to the function of the stem cell factor c-kit signaling pathway
Blood, July 30, 2002; 100(4): 1274 - 1286.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Maddens, A. Charruyer, I. Plo, P. Dubreuil, S. Berger, B. Salles, G. Laurent, and J.-P. Jaffrezou
Kit signaling inhibits the sphingomyelin-ceramide pathway through PLCgamma 1: implication in stem cell factor radioprotective effect
Blood, July 30, 2002; 100(4): 1294 - 1301.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. W. Krystal, S. Honsawek, D. Kiewlich, C. Liang, S. Vasile, L. Sun, G. McMahon, and K. E. Lipson
Indolinone Tyrosine Kinase Inhibitors Block Kit Activation and Growth of Small Cell Lung Cancer Cells
Cancer Res., May 1, 2001; 61(9): 3660 - 3668.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
E. Buchdunger, C. L. Cioffi, N. Law, D. Stover, S. Ohno-Jones, B. J. Druker, and N. B. Lydon
Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 139 - 145.
[Abstract] [Full Text]


Home page
BloodHome page
N. R. Leslie, J. O'Prey, C. Bartholomew, and P. R. Harrison
An Activating Mutation in the Kit Receptor Abolishes the Stroma Requirement for Growth of ELM Erythroleukemia Cells, But Does Not Prevent Their Differentiation in Response to Erythropoietin
Blood, December 15, 1998; 92(12): 4798 - 4807.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. H. Park, H. K. Plummer III, and G. W. Krystal
Selective Sp1 Binding Is Critical for Maximal Activity of the Human c-kit Promoter
Blood, December 1, 1998; 92(11): 4138 - 4149.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Ricotti, F. Fagioli, E. Garelli, C. Linari, N. Crescenzio, A. L. Horenstein, P. Pistamiglio, S. Vai, M. Berger, L. C. diMontezemolo, et al.
c-kit Is Expressed in Soft Tissue Sarcoma of Neuroectodermic Origin and Its Ligand Prevents Apoptosis of Neoplastic Cells
Blood, April 1, 1998; 91(7): 2397 - 2405.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Sattler, R. Salgia, G. Shrikhande, S. Verma, E. Pisick, K. V. S. Prasad, and J. D. Griffin
Steel Factor Induces Tyrosine Phosphorylation of CRKL and Binding of CRKL to a Complex Containing c-Kit, Phosphatidylinositol 3-Kinase, and p120CBL
J. Biol. Chem., April 11, 1997; 272(15): 10248 - 10253.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.